Fresenius Medical Care AG (FMS) Net Cash Flow (2009 - 2026)

Fresenius Medical Care AG's Net Cash Flow history runs 18 years deep, the most recent figure standing at -$443.3 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 400.53% year-over-year to -$443.3 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 87.49% YoY), while the FY2025 annual figure was $3.8 billion, up 66.45% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$443.3 million, down from $1.6 billion in the prior quarter.
• The five-year high for Net Cash Flow was $1.6 billion in Q4 2025, with the low at -$523.4 million in Q3 2025.
• The 5-year median for Net Cash Flow is $54.7 million (2022), against an average of $197.9 million.
• The sharpest annual moves came in 2024 and 2025: Net Cash Flow slumped 1167.17% in 2024, then soared 1133.92% in 2025.
• Fresenius Medical Care AG's Net Cash Flow stood at $872.4 million in 2022, then declined by 26.45% to $641.6 million in 2023, then decreased by 3.44% to $619.6 million in 2024, then jumped by 158.63% to $1.6 billion in 2025, then slumped by 127.67% to -$443.3 million in 2026.
• Business Quant data shows FMS's Net Cash Flow at -$443.3 million in Q1 2026, $1.6 billion in Q4 2025, and -$523.4 million in Q3 2025.